NASDAQ · Biotechnology

Windtree Therapeutics Inc (WINT)

$0.00 +50.00%

Add alert

29 Oversold Daily RSI (14)

Moving averages

SMA 200$0.09-99.67%

Company profile

Windtree Therapeutics, Inc., a clinical-stage biotechnology and medical device company, focuses on the development of therapies for the treatment of acute pulmonary and cardiovascular diseases.

SectorHealthcare

IndustryBiotechnology

Market cap$674,180

P/E ratio0.0001

EPS$323.08

Beta1.758

Dividend yield0.00%

52-week high$1.86

52-week low$0.01

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 48 VRTX Vertex Pharmaceuticals Inc RSI 46 CRSP CRISPR Therapeutics AG RSI 44 IOVA Iovance Biotherapeutics Inc RSI 69 RXRX Recursion Pharmaceuticals Inc - Class A RSI 53 MRNA Moderna Inc RSI 62 VKTX Viking Therapeutics Inc RSI 40 SRPT Sarepta Therapeutics Inc RSI 55 EDIT Editas Medicine Inc RSI 43 NVAX Novavax Inc RSI 57

Free forever

RSI alerts for WINT

Get an email the moment Windtree Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 15 September 2026 at 5:25 AM EDT